Go Pro
→ While SpaceX Gets the Spotlight, FJET Is Building What Comes Next! (From Trading Wire) (Ad)tc pixel Free PYC Stock Alerts

Physiomics (PYC) Competitors

Physiomics logo
GBX 0.52 -0.01 (-1.33%)
As of 05:09 AM Eastern
Compare

PYC vs. SNG, BVX, OBD, TLM, and NFX

Should you buy Physiomics stock or one of its competitors? Physiomics's main competitors and comparable companies include Synairgen (SNG), BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), Talisman Metals (TLM), and Nuformix (NFX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Physiomics compare to Synairgen?

Synairgen (LON:SNG) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

Synairgen has a beta of -2.23, suggesting that its stock price is 323% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.052, suggesting that its stock price is 5% more volatile than the broader market.

30.7% of Synairgen shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 3.2% of Synairgen shares are held by company insiders. Comparatively, 20.7% of Physiomics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Synairgen's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Synairgen Neutral
Physiomics Neutral

Synairgen has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Synairgen's return on equity of -51.06% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
SynairgenN/A -51.06% -30.58%
Physiomics -50.92%-89.43%-76.38%

Physiomics has higher revenue and earnings than Synairgen. Physiomics is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SynairgenN/AN/A-£15.86M-£1.66N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

Summary

Synairgen and Physiomics tied by winning 5 of the 10 factors compared between the two stocks.

How does Physiomics compare to BiVictriX Therapeutics?

BiVictriX Therapeutics (LON:BVX) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

BiVictriX Therapeutics has a beta of -0.73, meaning that its stock price is 173% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.052, meaning that its stock price is 5% more volatile than the broader market.

30.8% of BiVictriX Therapeutics shares are owned by institutional investors. Comparatively, 0.8% of Physiomics shares are owned by institutional investors. 42.6% of BiVictriX Therapeutics shares are owned by company insiders. Comparatively, 20.7% of Physiomics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, BiVictriX Therapeutics' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
BiVictriX Therapeutics Neutral
Physiomics Neutral

Physiomics has higher revenue and earnings than BiVictriX Therapeutics. Physiomics is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiVictriX TherapeuticsN/AN/A-£2.67M-£0.04N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

BiVictriX Therapeutics has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Physiomics' return on equity of -89.43% beat BiVictriX Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BiVictriX TherapeuticsN/A -103.99% -62.99%
Physiomics -50.92%-89.43%-76.38%

Summary

BiVictriX Therapeutics and Physiomics tied by winning 5 of the 10 factors compared between the two stocks.

How does Physiomics compare to Oxford BioDynamics?

Oxford BioDynamics (LON:OBD) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Physiomics has a net margin of -50.92% compared to Oxford BioDynamics' net margin of -825.61%. Physiomics' return on equity of -89.43% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford BioDynamics-825.61% -451.74% -56.23%
Physiomics -50.92%-89.43%-76.38%

Oxford BioDynamics has a beta of 0.42, indicating that its share price is 58% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.052, indicating that its share price is 5% more volatile than the broader market.

11.7% of Oxford BioDynamics shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 52.8% of Oxford BioDynamics shares are held by insiders. Comparatively, 20.7% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Physiomics has lower revenue, but higher earnings than Oxford BioDynamics. Physiomics is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford BioDynamics£1.20M3.95-£103.52M-£0.20N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

In the previous week, Oxford BioDynamics had 1 more articles in the media than Physiomics. MarketBeat recorded 1 mentions for Oxford BioDynamics and 0 mentions for Physiomics. Oxford BioDynamics' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Oxford BioDynamics Neutral
Physiomics Neutral

Summary

Oxford BioDynamics beats Physiomics on 7 of the 12 factors compared between the two stocks.

How does Physiomics compare to Talisman Metals?

Physiomics (LON:PYC) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Talisman Metals has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Talisman Metals' return on equity of 0.00% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Talisman Metals N/A N/A 3.70%

Physiomics has higher revenue and earnings than Talisman Metals. Physiomics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.46-£922.82K-£0.15N/A
Talisman MetalsN/AN/A-£1.35M£12.390.65

In the previous week, Physiomics' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Talisman Metals Neutral

Physiomics has a beta of 1.052, meaning that its share price is 5% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

0.8% of Physiomics shares are held by institutional investors. Comparatively, 1.4% of Talisman Metals shares are held by institutional investors. 20.7% of Physiomics shares are held by insiders. Comparatively, 95.2% of Talisman Metals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Talisman Metals beats Physiomics on 7 of the 10 factors compared between the two stocks.

How does Physiomics compare to Nuformix?

Nuformix (LON:NFX) and Physiomics (LON:PYC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Nuformix has a beta of 1.531, meaning that its stock price is 53% more volatile than the broader market. Comparatively, Physiomics has a beta of 1.052, meaning that its stock price is 5% more volatile than the broader market.

Nuformix has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Nuformix's return on equity of -83.53% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
NuformixN/A -83.53% -17.20%
Physiomics -50.92%-89.43%-76.38%

0.1% of Nuformix shares are owned by institutional investors. Comparatively, 0.8% of Physiomics shares are owned by institutional investors. 7.5% of Nuformix shares are owned by insiders. Comparatively, 20.7% of Physiomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Nuformix's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Nuformix Neutral
Physiomics Neutral

Nuformix has higher earnings, but lower revenue than Physiomics. Nuformix is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NuformixN/AN/A-£383.40K-£0.03N/A
Physiomics£953.01K2.46-£922.82K-£0.15N/A

Summary

Nuformix beats Physiomics on 6 of the 10 factors compared between the two stocks.

Get Physiomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYC vs. The Competition

Export
MetricPhysiomicsBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£2.35M£3.98B£7.31B£2.89B
Dividend Yield6.20%3.63%2.52%6.22%
P/E Ratio-3.4513.88274.10366.58
Price / Sales2.461,437.48672.6190,068.21
Price / Cash4.21113.2977.8027.89
Price / Book2.4815.4510.486.42
Net Income-£922.82K-£22.82M£3.49B£5.89B
7 Day Performance3.60%-1.68%-0.68%0.20%
1 Month Performance1.17%-6.15%-3.18%6.38%
1 Year Performance3.60%30.67%15.13%19.26%

Physiomics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
N/AGBX 0.52
-1.3%		N/A+8.4%£2.35M£953.01KN/A10
SNG
Synairgen
N/AN/AN/AN/A£9.04MN/AN/A34
BVX
BiVictriX Therapeutics
N/AN/AN/AN/A£8.25MN/AN/A17
OBD
Oxford BioDynamics
N/AGBX 0.12
+4.3%		N/A-74.8%£5.15M£1.20MN/A45
TLM
Talisman Metals
N/AGBX 7.48
+3.1%		N/AN/A£4.80MN/A0.605

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:PYC) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
Everyone remembers January's silver spike. Then what?
Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...
i2i Marketing Group, LLC | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...
American Alternative | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Arizona Gold Explorer Nears First-Ever Resource Estimate
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...
Wall Street Logic | Sponsoredtc pixel
Congress Passes Landmark Digital Asset Law Wall Street Is Watching
The House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...
Awesomely | Sponsoredtc pixel